logo
Plus   Neg
Share
Email

Aethlon Medical: FDA Allows Testing Of Hemopurifier In COVID-19; Shares Surge

Aethlon Medical, Inc. (AEMD) announced the FDA has approved a supplement to the existing Investigational Device Exemption for the company's Hemopurifier in viral disease to allow for the testing of the Hemopurifier in patients with SARS-CoV-2/COVID-19 in a new feasibility study. The study will enroll up to 40 subjects in the U.S.

The Aethlon Hemopurifier is a clinical-stage device designed to combat cancer and life-threatening viral infections. The Hemopurifier has previously been tested in patients with hepatitis C virus infection and in one patient with Ebola virus infection.

Shares of Aethlon Medical were up nearly 200% in pre-market trade on Thursday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
South Korea's Hyundai Motor Co. announced its decision to suspend production at its Asan plant for two days starting on Monday due to a chip shortage amid the pandemic crisis, Reuters reported. The company is experiencing trouble in supply conditions for semiconductor parts for powertrain control units. The Asan factory manufactures 300,000 vehicles, including the Sonata and Grandeur sedans, each The U.S. Department of Health and Human Services is set to expand its Health Center COVID-19 Vaccine Program to include all HRSA-funded health centers. This will increase the total number of health centers that have been invited to join the program to 1,470 nationwide from the earlier 950. McDonald's Corp. is planning to hire 25,000 workers in its restaurants across Texas in April, reports said. In a three-day event from April 13 to 15, the fast-food chain is expected to hire for crew and management positions. During these hiring days, participating McDonald's restaurants in the state will be accepting applications and interviewing job seekers.
Follow RTT